EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

hMSH2 coordinated with the expression of E2F1 promotes platinum response in epithelial ovarian cancer

Xiao-Qian Hu, Bao-Ying Zhang, Tian Hua iD

Journal of International Medical Research · 2023

DOI: 10.1177/03000605231163780 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of International Medical Research, 2023. Verfasst von Xiao-Qian Hu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Affiliated Xingtai People Hospital of Hebei Medical University, Xingtai, China. Hauptthemen laut MEDLINE: Carcinoma, Ovarian Epithelial, Cisplatin, E2F1 Transcription Factor, Ovarian Neoplasms. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To explore underlying mechanisms that regulate hMSH2 expression and drug susceptibility in epithelial ovarian cancer (EOC).

Methods

Using data from the Cancer Genome Atlas (TCGA) we used bioinformatical analysis to predict transcription factors (TFs) that potentially regulate hMSH2. RT-qPCR, Western blot, and luciferase assays were undertaken using ovarian cancer cell lines to verify the identified TF. Expressions of the TF were modulated using overexpression or knockdown, and the corresponding cellular responses to cisplatin were examined.

Results

The TF, E2F1, was found to regulate the hMSH2 gene. The expression level of E2F1 correlated with cisplatin susceptibility in vitro. Kaplan-Meier analysis of 77 patients with EOC showed that low E2F1 expression was associated with worse survival.

Conclusions

To our knowledge, this is the first report of E2F1 regulated MSH2 expression playing a role in drug resistance of platinum-based treatments for patients with EOC. Further work is need to confirm our results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Ovarian EpithelialCisplatinE2F1 Transcription FactorOvarian NeoplasmsMutS Homolog 2 ProteinFemaleHumansCell Line, TumorDrug Resistance, NeoplasmKaplan-Meier EstimatePlatinum

Stichwörter der Autor:innen

E2F1Mismatch repairPlatinum resistanceTranscription factorshMSH2

Substanzen

CisplatinE2F1 protein, humanE2F1 Transcription FactorPlatinumMSH2 protein, humanMutS Homolog 2 Protein

Autor:innen und Institutionen

  • Department of Oncology, Affiliated Xingtai People Hospital of Hebei Medical University, Xingtai, China.
  • Department of Gynaecology, Affiliated Xingtai People Hospital of Hebei Medical, University, Xingtai, China.

ORCID-Profile: Tian Hua

Zitieren

APA

Hu, X. Q., Zhang, B. Y., & Hua, T. (2023). hMSH2 coordinated with the expression of E2F1 promotes platinum response in epithelial ovarian cancer. Journal of International Medical Research. https://doi.org/10.1177/03000605231163780

Vancouver

Hu XQ, Zhang BY, Hua T. hMSH2 coordinated with the expression of E2F1 promotes platinum response in epithelial ovarian cancer. Journal of International Medical Research. 2023. doi:10.1177/03000605231163780

BibTeX
@article{Hu2023,
  author = {Hu, Xiao-Qian and Zhang, Bao-Ying and Hua, Tian},
  title = {hMSH2 coordinated with the expression of E2F1 promotes platinum response in epithelial ovarian cancer},
  journal = {Journal of International Medical Research},
  year = {2023},
  doi = {10.1177/03000605231163780}
}
Kostenlos starten →